Mode
Text Size
Log in / Sign up

Tiletamine-zolazepam provides rapid anesthetic induction for canine and feline patients with dose-dependent hemodynamic effectsTiletamine-zolazepam Provides Rapid Anesthesia for Dogs and Cats

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that tiletamine-zolazepam offers rapid induction but requires careful monitoring for dose-dependent respiratory effects.

This narrative review examines the clinical applications, pharmacology, and safety profiles of tiletamine-zolazepam for use in canine and feline patients. The authors synthesize information regarding its role as a non-competitive N-methyl-D-aspartate receptor antagonist (tiletamine) combined with a GABA neurotransmission modulator (zolazepam).

The review highlights that tiletamine-zolazepam provides rapid onset of anesthesia, though recovery profiles vary significantly between species due to differing metabolic rates. While the drug maintains a wide safety margin in healthy animals, it is contraindicated in cats with specific cardiorespiratory, hepatic, or renal diseases, as well as in cases involving head trauma or pregnancy.

Combinations with ketamine, xylazine, dexmedomidine, and opioids are noted to provide predictable anesthesia but may occasionally result in prolonged recovery. The authors note dose-dependent increases in sympathetic tone and potential respiratory depression. These findings underscore the necessity of balanced anesthesia and diligent monitoring to optimize safety for canine and feline patients.

How this fits prior evidence

This narrative review addresses a gap in specific pharmacological profiles for tiletamine-zolazepam in veterinary medicine. While prior coverage has established the role of dexmedetomidine in human ICU and pediatric settings, as well as the use of ketamine in prehospital trauma care, this review focuses specifically on the canine and feline applications of tiletamine-zolazepam. It provides specific contraindications for feline patients with hepatic or renal disease that were not addressed in previous coverage.

This review looks at how tiletamine-zolazepam works as an anesthetic for dogs and cats. It combines two components: tiletamine, which acts on certain receptors in the brain, and zolazepam, which affects neurotransmission. Together, they provide a rapid onset of anesthesia for patients.

When used alone or mixed with other medications like ketamine or opioids, the drug provides predictable results. However, combining it with other agents can sometimes lead to a longer recovery time for the animal. The review also notes that while the drug has a wide safety margin in healthy animals, its effects on heart rate and breathing depend on the specific dose given.

Careful monitoring is necessary because certain conditions can make this medication unsafe. It is not recommended for cats with liver or kidney disease, or those with heart problems. It is also avoided in cases of head trauma or pregnancy. Because this is a narrative review of existing literature rather than a new clinical trial, it serves as a guide for balanced anesthesia practices.

What this means for you:
Tiletamine-zolazepam provides fast anesthesia for pets but requires careful monitoring based on the animal's health.

Common questions

Is tiletamine-zolazepam safe for all pets?

It has a wide safety margin in healthy animals. However, it is not recommended for cats with heart, liver, or kidney disease. It is also avoided in cases of head trauma, increased intracranial pressure, or pregnancy. You should talk to your veterinarian about the specific health needs of your pet.

How quickly does the anesthesia start?

Tiletamine-zolazepam provides a rapid onset of anesthesia for both dogs and cats. The time it takes for an animal to recover from the medication can vary significantly between species because different animals have different metabolic rates.

Are there any side effects when mixed with other drugs?

Combining tiletamine-zolazepam with medications like ketamine, xylazine, dexmedetomidine, and opioids provides predictable anesthesia. However, these combinations can occasionally result in a prolonged recovery period for the animal.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedJun 2026
View Original Abstract ↓
Tiletamine-zolazepam is a widely utilized anesthetic combination in canine and feline medicine for chemical restraint, anesthetic induction, and minor surgical procedures. This narrative review synthesizes current evidence regarding the pharmacology, clinical applications, dosage regimens, and adverse effect profiles of tiletamine-zolazepam. Tiletamine functions as a non-competitive N-methyl-D-aspartate receptor antagonist, while zolazepam modulates gamma-aminobutyric acid neurotransmission. The combination provides a rapid onset of anesthesia, though recovery profiles vary significantly between species due to differing metabolic rates. In cats, intramuscular tiletamine-zolazepam is administered for immobilization and minor surgery; however, its use is contraindicated in cats with cardiorespiratory, hepatic, or renal disease. Clinical dosages are generally lower than manufacturer label recommendations, particularly for intravenous administration, which requires titration to clinical effect. In dogs, tiletamine-zolazepam is indicated for short procedures or as an induction drug prior to inhalant maintenance. Hemodynamic studies demonstrate dose-dependent increases in sympathetic tone and potential respiratory depression, necessitating peri-anesthetic monitoring, airway protection, and the integration of multimodal analgesia. Various combinations of tiletamine-zolazepam with ketamine, xylazine, dexmedetomidine, and opioids are commonly reported in veterinary medicine, offering predictable anesthesia but occasionally resulting in prolonged recovery. While tiletamine-zolazepam maintains a wide safety margin in healthy animals, it is contraindicated in those with head trauma, increased intracranial pressure, or pregnancy. This review underscores the necessity of balanced anesthesia and monitoring to optimize animal safety.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.